SEC Form 4 · accession 0002037144-26-000004
Structure Therapeutics Inc. · GPCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Crespo Blas Coll
Officer — CHIEF MEDICAL OFFICER
Period of report
Sep 18, 2026
Accepted (ET)
Sep 22, 2026 · 5:59 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001888886
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2,F3 | Sep 18, 2026 | F | 10,626 | $11.67 | D | 270,252 | D | |
| Ordinary SharesF4 | Sep 21, 2026 | C | 12,024 | $0.00 | D | 258,228 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| American Depositary SharesF4,F5 | — | Sep 21, 2026 | C | 4,008 | A | — | — | Ordinary Shares | 12,024 | 5,165 | D |
| American Depositary SharesF5 | — | Sep 21, 2026 | S | 4,008 | D | — | — | Ordinary Shares | 12,024 | 1,157 | D |
Explanation of responses
- F1The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.
- F2Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award.
- F3Reflects price per share in Ordinary Shares.
- F412,024 Ordinary Shares were converted into 4,008 American Depositary Shares as reported in Table II.
- F5Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.
- F6The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 30, 2026.